Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:    
Net income $ 1,026,065 $ 1,068,485
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 101,938 84,824
Loss on extinguishment of debt 13,286 0
Unrealized foreign exchange loss and other 1,783 15,639
Asset impairment charges 9,156 5,962
Disposal of non-controlling interest 8,270 0
Stock-based compensation expense 34,982 25,216
Gain on sale of business (29,687) 0
Deferred income taxes (156,226) (427,970)
Changes in assets and liabilities, net of assets acquired and liabilities assumed in business acquisitions:    
Accounts receivable (55,073) (180,354)
Inventories (265,530) (138,189)
Other assets 45,637 4,673
Accounts payable 36,472 41,868
Deferred system revenue (60,492) 33,469
Deferred service revenue (12,411) 4,912
Other liabilities 313,375 325,262
Net cash provided by operating activities 1,011,545 863,797
Cash flows from investing activities:    
Net proceeds from sale of business 75,358 0
Business acquisitions, net of cash acquired (27,144) (37,986)
Capital expenditures (84,352) (68,955)
Purchases of available-for-sale securities (256,793) (264,000)
Proceeds from sale of available-for-sale securities 26,608 14,954
Proceeds from maturity of available-for-sale securities 211,465 178,414
Purchases of trading securities (19,512) (22,896)
Proceeds from sale of trading securities 19,875 25,163
Proceeds from other investments 1,020 0
Net cash used in investing activities (53,475) (175,306)
Cash flows from financing activities:    
Payment of debt issuance costs (6,515) 0
Proceeds from revolving credit facility 300,000 300,000
Repayment of debt (662,250) (300,000)
Common stock repurchases (89,846) (399,677)
Payment of dividends to stockholders (187,984) (162,821)
Issuance of common stock 115 0
Tax withholding payments related to vested and released restricted stock units (54,952) (46,532)
Purchase of non-controlling interest (4,295) 0
Net cash used in financing activities (705,727) (609,030)
Effect of exchange rate changes on cash and cash equivalents (17,971) (4,507)
Net increase in cash and cash equivalents 234,372 74,954
Cash and cash equivalents at beginning of period 1,584,908 1,434,610
Cash and cash equivalents at end of period 1,819,280 1,509,564
Supplemental cash flow disclosures:    
Income taxes paid, net 101,061 57,532
Interest paid 44,216 39,717
Non-cash activities:    
Contingent consideration payable - financing activities 145 12,810
Dividends payable - financing activities 1,942 1,783
Unsettled common stock repurchase - financing activities 0 5,999
Accrued purchases of land, property and equipment - investing activities $ 34,027 $ 22,962